Entrolytics is Motilent's secure end-to-end medical imaging platform optimised for gastrointestinal data. Entrolytics makes it simple to organise, analyse and collaborate, with all your data in one place.

Learn more


GIQuant provides an objective score for small bowel disease in children and adults. It analyses MRI data to produce a disease activity score based on small bowel motility. Use it to quickly identify cases where medications are ineffective and thereby optimise patient management.

GIQuant is FDA cleared (Class II) and CE marked (Class IIa), it can be used for adults and children with routine MRE Data.

Learn more

Dynamic or 'cine' MRI offers a new and potentially powerful perspective on gastrointestinal function, especially in conditions like Crohn's where hypo-motility is related to disease activity. Objective assessment of this data with GIQuant could represent an important advance in how we quantify this in the clinic.

Professor Stuart Taylor - Consultant Radiologist, University College London

The digestive tract deserves to be better understood.

We’re on a mission to help patients by:

  • Supporting cutting edge research
  • Advancing clinical trials
  • Changing clinical practice

How can we support you to advance our understanding of digestive disease?

Motilent is a GI focused MedTech company. Our cloud-based platform Entrolytics is a hub bringing together your imaging, histopathology and endoscopy data. Entrolytics provides easy access to all data in one place alongside expert clinical markup, advanced image processing and AI. We turn great ideas into clinical change.

There's a lot to do to understand that 9 meter tube and Motilent's here to help!

Innovation at Motilent never stops.

Change the way you see the gut - get in touch today Get in touch